The Metabolic Toolbox

Home

What You Eat Influences Metabolic Syndrome

Metabolic syndrome (MetS) and inflammation are linked

MetS is a cluster of disruptions in the body's metabolism that affect energy generation and use. This can cause hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia. Atherogenic dyslipidemia has abnormal blood lipids. Namely, high amounts of triglycerides and small, low-dense lipoprotein (LDL) particles with low amounts of high-density lipoprotein (HDL) (Islam et al. 2024).

Inflammation causes and/or contributes to MetS. In turn, MetS causes inflammation. It is a positive feedback loop. Interestingly, there seems to be sex specific pathways that differ in women and men (Ter Horst et al. 2020).

Seven ways eating too many carbs lead to metabolic syndrome


You don't need to lose weight to reduce inflammation

Weight loss by most methods reduces the risk for MetS. However, many people find losing even small amounts of weight or excess fat difficult and annoying.

Rather than task people with potentially unattainable weight loss goals, we prefer to focus on diet recommendations that reduce both MetS symptoms and its associated metainflammation even without weight loss. One extremely effective treatment for MetS is replacing carbohydrates in the diet with protein and/or fat. Fat (adipose) tissue remodeling caused by metainflammation can be reversed through lifestyle changes such as changing the amounts of fat, carbohydrate and/or protein you eat or replacing processed food with whole natural foods (Volek et al. 2021).

You can reverse MetS by eating less carbohydrates and sugar

☆ A small crossover study found that people with MetS who eat a low-carbohydrate (LC) high fat diet rapidly reversed their MetS even without weight loss. Women and men (16 people, average age 41 years) who ate a low-carbohydrate (LC) diet for 4 weeks accelerated fat oxidation while reversing MetS when compared to the same people eating a high carbohydrate diet. Nine out of the 16 people no longer met the criteria for MetS after only 4 weeks of the LC diet. All showed positive changes.

Eating a LC diet lowered triglycerides, increased HDL-C, improved LDL phenotype and decreased plasma total saturated fatty acids.

All diets were 20% protein. LC diet was 6% carb, medium carb (MC) diet was 32% carb, and HC was 57% carb. Fat content of each diet was LC=74%, MC=48%, and HC=23% energy (Hyde et al. 2019).

☆ A review found that caloric intake was not related to changes in MetS factors. However, similar to above, diets lower in carbs and higher in fat were the most relevant for improving MetS markers (Willems et al. 2021).

Interested in losing weight? Willems et al. 2021 found that increasing your protein intake was associated with reducing your body weight. For best results replace carbohydrates with protein.

Below: Drinking soda for breakfast is not the best choice. Photo of Swedish custom officer (1967) on a break by Lennart Nygren.

Lennart Nygren, Public domain, via Wikimedia Commons


7 ways eating too many carbohydrates (especially sugars and processed carbohydrates) leads to metabolic syndrome

Click on each one for more details!

1) Fructose metabolism triggers metabolic changes promoting inflammation, insulin resistance (IR), cardiometabolic disorders and uric acid generation. Most fructose comes from sugar, not fruits. Table sugar is half fructose and half sucrose.

Leading sources of fructose: soda and fruit juices. Beverages listing high fructose corn syrup as an ingredient have an average of 60% fructose to 40% glucose. Beverages made with sugar have around 50% fructose and 50% glucose (Walker et al. 2014).

One medium apple contains around 11-12 g fructose. One can of Coke or Pepsi has 39-40 grams of sugar. Apples also contain fiber and vitamins.

2) High carbohydrate diets (especially processed carbohydrates) lead to development of IR over time in many people.

3) High carbohydrate consumption increases blood glucose which leads to mitochondria dysfunction and IR.

4) Excess sugar consumption stimulates leptin resistance. Leptin is a hormone that helps your body maintain weight by regulating hunger.

5) Carbohydrate consumption causes changes to the gut microbiotia.

6) Excess carbohydrate consumption promotes weight gain through overeating.

7) When you consume a high carbohydrate and low fat diet you use less calories to digest your meal. This promotes obesity.

It is likely that the ill effects of overindulgence in carbohydrates stems from a combination of these pathways.

*Hasan E. (53 year man) "I am a type 2 diabetic. I can't keep my sugar levels under control without restricting my carbs. As the carbs get lower I feel better physically and cognitively. I really try to keep to 100-110 carbs a day. My body prefers I stay under like 30 carbs a meal, I guess.

If I pig out on pizza or soda for dinner, my body feels like trash. Fatigue hits and I start having focus problems and brain fog... I don't want to end up with amputated feet, so I just keep to a lower carb lifestyle, and I usually feel much better. I need some carbs though, Keto is really too low and saps my energy."

Check out below for all the good scientific evidence!

Ministry of Food, Public domain, via Wikimedia Commons

Excess carbohydrate intake triggers metabolic syndrome

There is amble evidence that excess carbohydrate consumption, in particular excess sugar and/or processed carbohydrate consumption, is associated with the symptoms of MetS. This same overwhelming volume of evidence is not seen with excess dietary fat and/or protein intake.

Need proof? Excess carbohydrate and/or sugar consumption is correlated with:

★ MetS (Dhingra et al. 2007, Denova-Gutierrez et al. 2010, Hyde et al. 2019, Willems et al. 2021, Kuo et al. 2023)

★ Type 2 diabetes (T2D); this is especially true of consuming both sugar sweetened and artificially sweetened beverages! (Schulze et al. 2004, Montonen et al. 2007, Bhupathiraju et al. 2013, Tay et al. 2015, Imamura et al. 2016, Tay et al. 2018, Volek et al. 2021, Pavlidou et al. 2023, Della Corte et al. 2025)

★ Insulin resistance (IR); IR can lead to T2D and weight gain (Bremer et al. 2010, O'Neill 2020, Ebbeling et al. 2022, Pavlidou et al. 2023)

★ Dysfunctional lipid levels that include high triglycerides (Denova-Gutierrez et al. 2010, Tay et al. 2018, Ebbeling et al. 2022)

★ Cardiovascular disease like heart failure or strokes (Hu and Bazzano 2014, Dong et al. 2020)

★ Central adiposity or large waist circumference (Garr Barry et al. 2021)

★ Non-alcohol fatty liver disease (NAFLD). This is aggravated by fructose consumption (table sugar is half fructose and half glucose) (Ouyang et al. 2008, Umpleby et al. 2017, Lambertz et al. 2017, Jensen et al. 2018)

★ Hyperuricemia, high levels of uric acid which can cause gout or kidney stones (Thottam et al. 2017)

Keep in mind that you may react very differently to various types of carbohydrates

People react differently to different types of carbohydrates depending on their genetic makeup. Researchers looked at how 55 people with no history of Type 2 Diabetes (T2D) reacted to different standardized carbohydrate meals by measuring glucose response (how much their glucose goes up, called a spike).

The seven carbohydrate meals (50 g total carbohydrates each) were:

1) jasmine rice

2) buttermilk bread

3) shredded cooked and cooled potatoes

4) precooked and previously frozen macaroni pasta

5) canned black beans (high fiber)

6) mixed blackberries, strawberries and blueberries (high fiber)

7) grapes (low fiber)

People had different glucose spikes to the various carbs: the largest glucose responses were seen with rice 35%, bread 24% and grapes 22%. Insulin resistant (IR) people had more extreme responses to the meals. Asian people were more likely to react strongly to rice. People who were more IR, had higher fasting glucose, and had lower pancreas beta cell function reacted more strongly to potatoes. Those who were more insulin sensitive reacted more to grapes. Bread spikers had higher blood pressure (Wu et al. 2025).

What can you do?

Some people test their reactions to carbohydrates using a blood glucose meter. These are very cheap and easy to use.

Often you can tell what carbohydrates raise your blood glucose/sugar levels by seeing what foods make you feel either sluggish or really hungry soon after you eat them.

berries by Susan Fluegel

Blue Box of Science: Want to know the details? Here are the references and hard science.

1) Fructose metabolism leads to metabolic changes that increase metainflammation, IR and visceral adiposity (Basciano et al. 2005, Stanhope and Havel 2009, DiNicolantonio et al. 2015). Table sugar, sucrose, is composed of half fructose and half glucose, so diets high in refined carbohydrates and added sugars contain approximately 50% fructose.

Glucose can be used directly by cells or by the liver, but most dietary fructose is processed by the liver in a procedure initiated by fructokinase (Teff et al. 2009, Zhang et al. 2017). Unlike the enzymes that initiate glucose processing, fructokinase is not regulated by hepatic energy status as measured by ATP (Adelman et al. 1967). Due to this, fructose consumption leads to unchecked increases in de novo lipogenesis (DNL), triglycerides, carbohydrate oxidation, and liver fat even without weight gain (Schwarz et al. 2015).

In addition, rapid fructose metabolism depletes liver ATP and intracellular inorganic phosphate (Pi) levels (Van den Berghe et al. 1977, Abdelmalek et al. 2012), ultimately causing a buildup of uric acid and adenosine monophosphate deaminase (AMPD). Both uric acid and AMPD adversely regulate energy sensor AMP kinase (AMPK). AMPK inhibits fatty liver and has anti-inflammatory effects in cells such as leukocytes (Smith et al. 2016, Zhang et al. 2017). Thus, restricting AMPK may promote fatty liver and inflammation.

Fructose metabolism interacts with purine degradation pathways to further increase uric acid generation (Thottam et al. 2017). Interestingly, urate also promotes fructokinase which generates a positive feedback loop ultimately resulting in even higher uric acid levels (Lanaspa et al. 2012, Jensen et al. 2018). Uric acid increases metabolic and oxidative stress partly by inducing mitochondrial oxidative stress (Xie et al. 2021).

Healthy mitochondria are one of the main generators of reactive oxygenated species (ROS) and other free radicals (Bhatti et al. 2017, Choi et al. 2024). Stressed mitochondria release even more free radicals due to electron transport chain dysfunction. As the mitochondria deteriorate ATP production decreases and free radical production increases.

Increased ROS damages the mitochondria further promoting a positive feedback cycle (Bhatti et al. 2017). In turn, mitochondrial oxidative stress promotes IR, hypertension and cardiac dysfunctions (Dikalov and Zoltan Ungvari 2013). Stressed mitochondria contribute to NAFLD pathology as well by generating ROS that trigger inflammation, damage hepatocytes, and contribute to IR (Bhatti et al. 2017).

Willem van Aelst, Fruit Still Life with a Snail, c1649 oil on canvas.

Willem van Aelst, Public domain, via Wikimedia Commons

2) Excessive carbohydrate consumption may lead to insulin resistance (IR) over time. Highly refined carbohydrate consumption is a risk factor for MetS, weight gain, fatty liver and IR (Bray and Popkin 2014, Lopez-Alarcon et al. 2014).

Refined carbohydrates and sugars enter the blood stream quickly as simple sugars (mainly glucose and fructose). High blood glucose triggers insulin release by the pancreas to balance blood glucose (Qaid and Adelrahman 2016). Insulin; a hypoglycemic, anabolic and storage hormone; stimulates cellular glucose transport protein, GLUT4, to rise to the cell’s membrane surface and take up glucose. To maximize glucose storage, insulin promotes lipoprotein lipase (LPL), a fat storage enzyme, and suppresses hormone sensitive lipase (HSL), an enzyme that breaks down triglycerides. Insulin also suppresses liver glucose production, gluconeogenesis (Edgerton et al. 2017).

Insulin concentrations are higher on a high carbohydrate diet than a low carbohydrate diet (Hernandez et al. 2010). Chronic hyperinsulinemia may promote metainflammation and obesity . Over time, cells become less sensitive to the chronically high insulin levels and more insulin has to be produced to balance blood glucose. This process may be initiated or accelerated by chronic inflammation (Wensveen et al. 2015, Kumar et al. 2018). Chronically elevated insulin concentrations promote cellular IR and obesity. Cellular IR prompts increased insulin release and the cycle accelerates.

3) High carbohydrate diets increase blood glucose after a meal (postprandial) when compared to lower carbohydrate diets (Feinman et al. 2015). High blood glucose concentrations influence mitochondrial dynamics, promoting overproduction of ROS and insulin resistance (IR) (Patti and Corvera 2010, Zheng et al. 2015, Fung and Berger 2016, Wang and Wei 2017).

IR, in turn, is linked to several mitochondria abnormalities including systemic inflammation (Fung and Berger 2016). IR reduces insulin-stimulated mitochondrial activity due to stunted mitochondrial plasticity (Szendroedi et la. 2012). A reduction in mitochondria plasticity means that mitochondria are unable to effectively switch fuels from fatty acids to glucose in skeletal muscle. IR also significantly decreases the copy number of mitochondrial DNA (mtDNAn). A reduction in mtDNAn precedes diabetes development and predicts IR (Zheng et al. 2015). 

4) Fructose and sucrose intake may promote obesity and leptin resistance through several mechanisms including alterations in central and peripheral metabolism and/or leptin receptor signaling (Vasselli et al. 2013). Leptin is an adipocyte hormone that helps balance food intake with energy expenditure in the hypothalamus. Higher concentrations of leptin decrease appetite, switch food preferences from fatty acids to carbohydrates, and promote thermogenesis through UCP3 activation in muscle tissue. Chronic fructose consumption caused leptin resistance and increased susceptibility to overeating and weight gain in rats (Shapiro et al. 2008).

Diets containing excessive fructose affects regulatory pathways for energy homeostasis even without weight gain (Vasselli et al. 2013). Weight maintaining diets high in fructose prime rats to overeat when they are later put on an obesogenic diet (Shapiro et al. 2008, Vasselli et al. 2013). High fructose diets quickly induce leptin resistance (Shapiro et al. 2008). Fructose-induced leptin resistance may initiate a chain reaction contributing to the rapid weight gain of animals later exposed to a more palatable high caloric diet. (Vasselli et al. 2013). Interestingly, high fat diets seem to protect against fructose-initiated leptin resistance (Haring and Harris 2011). This may explain the conflicting studies on this topic.

Humans are more complicated. For one thing, it is harder to measure leptin resistance in humans since there is no overreaching definition of this disorder. Overall, when people overeat carbohydrates, fructose, sucrose, and saturated fat while neglecting protein, they can become leptin resistant (Mendoza-Herrera et al. 2021). Low calorie diets and weight loss can reverse leptin resistance.

Evaristo Baschenis - Boy with a Basket of Bread c1655-65 oil on canvas.

Evaristo Baschenis, Public domain, via Wikimedia Commons

5) There is evidence that lower carbohydrate diets shift gut microbiota composition (Rondanelli et al. 2021). Gut microbiota composition may be associated with body weight. Several exploratory studies report that prebiotics and probiotics improve insulin sensitivity, inflammatory markers, postprandial incretins, and glucose tolerance. This is an emerging field and more research is needed (see discussion Mora-Flores et al. 2023).

6) High carbohydrate diets may promote overeating. Parvaresh Rizi et al. (2018) noted that obese men who consumed a high carbohydrate meal had a less favorable postprandial satiety and appetite hormonal response compared to when they consumed either a high fat or a high protein meal. In addition, Ebbeling et al. 2018 reported higher ghrelin and leptin concentrations in people consuming a 60% carbohydrate, 20% fat diet compared to those consuming a 20% carbohydrate, 60% fat diet. Ghrelin is a circulating orexigenic hormone that increases hunger in the short term. Leptin, produced by fat cells, is an endocrine adiposity factors that inhibits appetite while interacting with insulin. However, obese people develop leptin resistance which results in higher amounts of circulating leptin.

7) People who eat high amounts of carbohydrates burn less calories. Low fat, high carbohydrate diets decreased resting energy expenditure (REE) and total energy expenditure (TEE) compared to high fat, low carbohydrate diets (Ebbeling et al. 2012, Ebbeling et al. 2018). Ebbeling et al. (2018) reported a linear trend of an additional 52 kcal/d used for every 10% decrease of carbohydrate to total energy intake. In the same study, people who had high levels of insulin secretion burned even more calories with a high fat diet compared to a high carbohydrate diet.

Similarly, high glycemic load diets had a lower REE than high glycemic load diets (Pereira et al. 2004, Ebbeling et al. 2012). This means that people would use more energy on a lower carbohydrate diet compared to a higher carbohydrate diet. A lower carbohydrate diet is more likely to increase weight loss during dieting and increase energy expenditure during weight maintenance (Ebbeling et al. 2018).

Consuming excess energy can increase mitochondria oxidative stress. From 0.4-4% of the oxygen used by mitochondria is incompletely consumed and results in primary ROS (Murphy 2009). Electrons escaping during electron transfer in the ETC produce ROS. This is more likely to occur in mitochondria when there is a large proton gradient build-up. Large proton gradients occur when energy consumption (NADH production) is excessive or when there is a functional impairment of one of the electron transport complexes (Murphy 2009, Bhatti et al. 2017).

bee by Susan Fluegel

cardiometabolic disorders: a cluster of related risk factors such as high blood pressure, fat around the middle, high triglycerides, weird blood fats and high fasting blood sugar.

*Names and some minor identifying details in all stories in this website are changed to protect people's privacy

I'm not your doctor so this is not medical information. I'm just a person who would like to see you happy and healthy. If you have any questions or concerns about starting an exercise regiment, diet program, or supplements please consult a professional.

References:

Abdelmalek MF, Lazo M, Horska A, Bonekamp S, Lipkin EW, Balasubramanyam A, Bantle JP, Johnson RJ, Diehl AM, Clark JM; Fatty Liver Subgroup of Look AHEAD Research Group. Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes. Hepatology. 2012 Sep;56(3):952-60. doi: 10.1002/hep.25741. Full article.

Adelman RC, Morris HP, Weinhouse S. Fructokinase, triokinase, and aldolases in liver tumors of the rat. Cancer Res. 1967 Dec;27(12):2408-13. PMID: 6082288. No abstract online.

Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond). 2005 Feb 21;2(1):5. doi: 10.1186/1743-7075-2-5. Full article.

Bhatti JS, Bhatti GK, Reddy PH. Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1066-1077. doi: 10.1016/j.bbadis.2016.11.010. Full article.

Bhupathiraju SN, Pan A, Malik VS, Manson JE, Willett WC, van Dam RM, Hu FB. Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr. 2013 Jan;97(1):155-66. doi: 10.3945/ajcn.112.048603. Full article.

Bray GA, Popkin BM. Dietary sugar and body weight: have we reached a crisis in the epidemic of obesity and diabetes?: health be damned! Pour on the sugar. Diabetes Care. 2014 Apr;37(4):950-6. doi: 10.2337/dc13-2085. Full article.

Bremer AA, Auinger P, Byrd RS. Sugar-Sweetened Beverage Intake Trends in US Adolescents and Their Association with Insulin Resistance-Related Parameters. J Nutr Metab. 2010;2010:196476. doi: 10.1155/2010/196476. Full article.

Choi EH, Kim MH, Park SJ. Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment. Int J Mol Sci. 2024 Jul 21;25(14):7952. doi: 10.3390/ijms25147952. Full article.

Della Corte KA, Bosler T, McClure C, Buyken AE, LeCheminant JD, Schwingshackl L, Della Corte D. Dietary Sugar Intake and Incident Type 2 Diabetes Risk: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies. Adv Nutr. 2025 May;16(5):100413. doi: 10.1016/j.advnut.2025.100413. Full article.

Denova-Gutiérrez E, Talavera JO, Huitrón-Bravo G, Méndez-Hernández P, Salmerón J. Sweetened beverage consumption and increased risk of metabolic syndrome in Mexican adults. Public Health Nutr. 2010 Jun;13(6):835-42. doi: 10.1017/S1368980009991145. Full article.

De Nucci S, Rinaldi R, Di Chito M, Donghia R, Giannuzzi V, Shahini E, Cozzolongo R, Pesole PL, Coletta S, De Pergola G, Giannelli G. The Replacement of Only One Portion of Starchy Carbohydrates with Green Leafy Vegetables Regresses Mid and Advanced Stages of NAFLD: Results from a Prospective Pilot Study. Nutrients. 2023 May 12;15(10):2289. doi: 10.3390/nu15102289. Full article.

Dikalov SI, Ungvari Z. Role of mitochondrial oxidative stress in hypertension. Am J Physiol Heart Circ Physiol. 2013 Nov 15;305(10):H1417-27. doi: 10.1152/ajpheart.00089.2013. Full article.

DiNicolantonio JJ, O'Keefe JH, Lucan SC. Added fructose: a principal driver of type 2 diabetes mellitus and its consequences. Mayo Clin Proc. 2015 Mar;90(3):372-81. doi: 10.1016/j.mayocp.2014.12.019. Full article.

Dhingra R, Sullivan L, Jacques PF, Wang TJ, Fox CS, Meigs JB, D'Agostino RB, Gaziano JM, Vasan RS. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation. 2007 Jul 31;116(5):480-8. doi: 10.1161/CIRCULATIONAHA.107.689935. Epub 2007 Jul 23. Erratum in: Circulation. 2007 Dec 4;116(23):e557. PMID: 17646581. Full article.

Dong T, Guo M, Zhang P, Sun G, Chen B. The effects of low-carbohydrate diets on cardiovascular risk factors: A meta-analysis. PLoS One. 2020 Jan 14;15(1):e0225348. doi: 10.1371/journal.pone.0225348. Full article.

Ebbeling CB, Feldman HA, Klein GL, Wong JMW, Bielak L, Steltz SK, Luoto PK, Wolfe RR, Wong WW, Ludwig DS. Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial. BMJ. 2018 Nov 14;363:k4583. doi: 10.1136/bmj.k4583. Erratum in: BMJ. 2020 Nov 3;371:m4264. doi: 10.1136/bmj.m4264. Full article.

Ebbeling CB, Knapp A, Johnson A, Wong JMW, Greco KF, Ma C, Mora S, Ludwig DS. Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia-a randomized controlled feeding trial. Am J Clin Nutr. 2022 Jan 11;115(1):154-162. doi: 10.1093/ajcn/nqab287. Erratum in: Am J Clin Nutr. 2022 Jan 11;115(1):310. doi: 10.1093/ajcn/nqab372. Full article.

Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607. Full article.

Edgerton DS, Kraft G, Smith M, Farmer B, Williams PE, Coate KC, Printz RL, O'Brien RM, Cherrington AD. Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion. JCI Insight. 2017 Mar 23;2(6):e91863. doi: 10.1172/jci.insight.91863. Full article.

Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, Accurso A, Frassetto L, Gower BA, McFarlane SI, Nielsen JV, Krarup T, Saslow L, Roth KS, Vernon MC, Volek JS, Wilshire GB, Dahlqvist A, Sundberg R, Childers A, Morrison K, Manninen AH, Dashti HM, Wood RJ, Wortman J, Worm N. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition. 2015 Jan;31(1):1-13. doi: 10.1016/j.nut.2014.06.011. Epub 2014 Jul 16. Erratum in: Nutrition. 2019 Jun;62:213. doi: 10.1016/j.nut.2018.12.002. Full article.

Fung J, Berger A. Hyperinsulinemia and Insulin Resistance: Scope of the Problem. Journal of Insulin Resistance. 2016;1(1), a18. http://dx.doi.org/10.4102/jir.v1i1.18 Full article.

Garr Barry V, Stewart M, Soleymani T, Desmond RA, Goss AM, Gower BA. Greater Loss of Central Adiposity from Low-Carbohydrate versus Low-Fat Diet in Middle-Aged Adults with Overweight and Obesity. Nutrients. 2021 Jan 31;13(2):475. doi: 10.3390/nu13020475. Full article.

Haring SJ, Harris RB. The relation between dietary fructose, dietary fat and leptin responsiveness in rats. Physiol Behav. 2011 Oct 24;104(5):914-22. doi: 10.1016/j.physbeh.2011.05.032. Full article.

Hernandez TL, Sutherland JP, Wolfe P, Allian-Sauer M, Capell WH, Talley ND, Wyatt HR, Foster GD, Hill JO, Eckel RH. Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet. Am J Clin Nutr. 2010 Mar;91(3):578-85. doi: 10.3945/ajcn.2009.27909. Full article.

Hyde PN, Sapper TN, Crabtree CD, LaFountain RA, Bowling ML, Buga A, Fell B, McSwiney FT, Dickerson RM, Miller VJ, Scandling D, Simonetti OP, Phinney SD, Kraemer WJ, King SA, Krauss RM, Volek JS. Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. JCI Insight. 2019 Jun 20;4(12):e128308. doi: 10.1172/jci.insight.128308. Full article.

Hu T, Bazzano LA. The low-carbohydrate diet and cardiovascular risk factors: evidence from epidemiologic studies. Nutr Metab Cardiovasc Dis. 2014 Apr;24(4):337-43. doi: 10.1016/j.numecd.2013.12.008. Full article.

Imamura F, O'Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. Br J Sports Med. 2016 Apr;50(8):496-504. doi: 10.1136/bjsports-2016-h3576rep. Full article.

Imamura F, O'Connor L, Ye Z, Mursu J, Hayashino Y, Bhupathiraju SN, Forouhi NG. Consumption of sugar sweetened beverages, artificially sweetened beverages, and fruit juice and incidence of type 2 diabetes: systematic review, meta-analysis, and estimation of population attributable fraction. BMJ. 2015 Jul 21;351:h3576. doi: 10.1136/bmj.h3576. Full article.

Islam MS, Wei P, Suzauddula M, Nime I, Feroz F, Acharjee M, Pan F. The interplay of factors in metabolic syndrome: understanding its roots and complexity. Mol Med. 2024 Dec 27;30(1):279. doi: 10.1186/s10020-024-01019-y. Full article.

Jensen T, Abdelmalek MF, Sullivan S, Nadeau KJ, Green M, Roncal C, Nakagawa T, Kuwabara M, Sato Y, Kang DH, Tolan DR, Sanchez-Lozada LG, Rosen HR, Lanaspa MA, Diehl AM, Johnson RJ. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. J Hepatol. 2018 May;68(5):1063-1075. doi: 10.1016/j.jhep.2018.01.019. Full article.

Kumar D, Shankar K, Patel S, Gupta A, Varshney S, Gupta S, Rajan S, Srivastava A, Vishwakarma AL, Gaikwad AN. Chronic hyperinsulinemia promotes meta-inflammation and extracellular matrix deposition in adipose tissue: Implications of nitric oxide. Mol Cell Endocrinol. 2018 Dec 5;477:15-28. doi: 10.1016/j.mce.2018.05.010. Full article.

Kuo CT, Chen DR, Chan CC, Yeh YP, Chen HH. Sex differences in the association between sugar-sweetened beverages consumption and metabolic risks among the working-age population in Taiwan. Public Health Nutr. 2023 Mar;26(3):653-660. doi: 10.1017/S1368980022001549. Full article.

Lanaspa MA, Sanchez-Lozada LG, Cicerchi C, Li N, Roncal-Jimenez CA, Ishimoto T, Le M, Garcia GE, Thomas JB, Rivard CJ, Andres-Hernando A, Hunter B, Schreiner G, Rodriguez-Iturbe B, Sautin YY, Johnson RJ. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver. PLoS One. 2012;7(10):e47948. doi: 10.1371/journal.pone.0047948. Full article.

Lambertz J, Weiskirchen S, Landert S, Weiskirchen R. Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease. Front Immunol. 2017 Sep 19;8:1159. doi: 10.3389/fimmu.2017.01159. Full article.

López-Alarcón M, Perichart-Perera O, Flores-Huerta S, Inda-Icaza P, Rodríguez-Cruz M, Armenta-Álvarez A, Bram-Falcón MT, Mayorga-Ochoa M. Excessive refined carbohydrates and scarce micronutrients intakes increase inflammatory mediators and insulin resistance in prepubertal and pubertal obese children independently of obesity. Mediators Inflamm. 2014;2014:849031. doi: 10.1155/2014/849031. Full article.

Mendoza-Herrera K, Florio AA, Moore M, Marrero A, Tamez M, Bhupathiraju SN, Mattei J. The Leptin System and Diet: A Mini Review of the Current Evidence. Front Endocrinol (Lausanne). 2021 Nov 24;12:749050. doi: 10.3389/fendo.2021.749050. Full article.

Montonen J, Järvinen R, Knekt P, Heliövaara M, Reunanen A. Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr. 2007 Jun;137(6):1447-54. doi: 10.1093/jn/137.6.1447. Full article.

Mora-Flores LP, Moreno-Terrazas Casildo R, Fuentes-Cabrera J, Pérez-Vicente HA, de Anda-Jáuregui G, Neri-Torres EE. The Role of Carbohydrate Intake on the Gut Microbiome: A Weight of Evidence Systematic Review. Microorganisms. 2023 Jun 30;11(7):1728. doi: 10.3390/microorganisms11071728. Full article.

Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009 Jan 1;417(1):1-13. doi: 10.1042/BJ20081386. Full article.

O'Neill BJ. Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome. Curr Opin Endocrinol Diabetes Obes. 2020 Oct;27(5):301-307. doi: 10.1097/MED.0000000000000569. Abstract.

Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008 Jun;48(6):993-9. doi: 10.1016/j.jhep.2008.02.011. Full article.

Patti ME, Corvera S. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocr Rev. 2010 Jun;31(3):364-95. doi: 10.1210/er.2009-0027. Full article.

Parvaresh Rizi E, Loh TP, Baig S, Chhay V, Huang S, Caleb Quek J, Tai ES, Toh SA, Khoo CM. A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men. PLoS One. 2018 Jan 31;13(1):e0191609. doi: 10.1371/journal.pone.0191609. Full article.

Pavlidou E, Papadopoulou SK, Fasoulas A, Mantzorou M, Giaginis C. Clinical Evidence of Low-Carbohydrate Diets against Obesity and Diabetes Mellitus. Metabolites. 2023 Feb 6;13(2):240. doi: 10.3390/metabo13020240. Full article.

Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA. 2004 Nov 24;292(20):2482-90. doi: 10.1001/jama.292.20.2482. Full article.

Qaid MM, Abdelrahman MM. Role of insulin and other related hormones in energy metabolism—A review.Cogent Food & Agriculture. 2016 2(1). https://doi.org/10.1080/23311932.2016.1267691 Full article.

Rondanelli M, Gasparri C, Peroni G, Faliva MA, Naso M, Perna S, Bazire P, Sajuox I, Maugeri R, Rigon C. The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition. Front Endocrinol (Lausanne). 2021 May 14;12:662591. doi: 10.3389/fendo.2021.662591. Erratum in: Front Endocrinol (Lausanne). 2021 Dec 22;12:825790. doi: 10.3389/fendo.2021.825790. Full article.

Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC, Hu FB. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004 Aug 25;292(8):927-34. doi: 10.1001/jama.292.8.927. Full article.

Shapiro A, Mu W, Roncal C, Cheng KY, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol. 2008 Nov;295(5):R1370-5. doi: 10.1152/ajpregu.00195.2008. Full article.

Smith BK, Marcinko K, Desjardins EM, Lally JS, Ford RJ, Steinberg GR. Treatment of nonalcoholic fatty liver disease: role of AMPK. Am J Physiol Endocrinol Metab. 2016 Oct 1;311(4):E730-E740. doi: 10.1152/ajpendo.00225.2016. Full article.

Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest. 2009 May;119(5):1322-34. doi: 10.1172/JCI37385. Full article.

Szendroedi J, Phielix E, Roden M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2011 Sep 13;8(2):92-103. doi: 10.1038/nrendo.2011.138. Abstract.

Tappy L, Rosset R. Health outcomes of a high fructose intake: the importance of physical activity. J Physiol. 2019 Jul;597(14):3561-3571. doi: 10.1113/JP278246. Full article.

Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, Yancy WS Jr, Brinkworth GD. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am J Clin Nutr. 2015 Oct;102(4):780-90. doi: 10.3945/ajcn.115.112581. Full article.

Tay J, Thompson CH, Luscombe-Marsh ND, Wycherley TP, Noakes M, Buckley JD, Wittert GA, Yancy WS Jr, Brinkworth GD. Effects of an energy-restricted low-carbohydrate, high unsaturated fat/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: A 2-year randomized clinical trial. Diabetes Obes Metab. 2018 Apr;20(4):858-871. doi: 10.1111/dom.13164. Abstract.

Teff KL, Grudziak J, Townsend RR, Dunn TN, Grant RW, Adams SH, Keim NL, Cummings BP, Stanhope KL, Havel PJ. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab. 2009 May;94(5):1562-9. doi: 10.1210/jc.2008-2192. Full article.

Ter Horst R, van den Munckhof ICL, Schraa K, Aguirre-Gamboa R, Jaeger M, Smeekens SP, Brand T, Lemmers H, Dijkstra H, Galesloot TE, de Graaf J, Xavier RJ, Li Y, Joosten LAB, Rutten JHW, Netea MG, Riksen NP. Sex-Specific Regulation of Inflammation and Metabolic Syndrome in Obesity. Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1787-1800. doi: 10.1161/ATVBAHA.120.314508. Full article.

Thottam GE, Krasnokutsky S, Pillinger MH. Gout and Metabolic Syndrome: a Tangled Web. Curr Rheumatol Rep. 2017 Aug 26;19(10):60. doi: 10.1007/s11926-017-0688-y. Abstract.

Umpleby AM, Shojaee-Moradie F, Fielding B, Li X, Marino A, Alsini N, Isherwood C, Jackson N, Ahmad A, Stolinski M, Lovegrove JA, Johnsen S, Jeewaka R Mendis AS, Wright J, Wilinska ME, Hovorka R, Bell JD, Thomas EL, Frost GS, Griffin BA. Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets. Clin Sci (Lond). 2017 Oct 17;131(21):2561-2573. doi: 10.1042/CS20171208. Full article.

van den Berghe G, Bronfman M, Vanneste R, Hers HG. The mechanism of adenosine triphosphate depletion in the liver after a load of fructose. A kinetic study of liver adenylate deaminase. Biochem J. 1977 Mar 15;162(3):601-9. doi: 10.1042/bj1620601. Full article.

Vasselli JR, Scarpace PJ, Harris RB, Banks WA. Dietary components in the development of leptin resistance. Adv Nutr. 2013 Mar 1;4(2):164-75. doi: 10.3945/an.112.003152. Full article.

Volek JS, Phinney SD, Krauss RM, Johnson RJ, Saslow LR, Gower B, Yancy WS Jr, King JC, Hecht FM, Teicholz N, Bistrian BR, Hamdy O. Alternative Dietary Patterns for Americans: Low-Carbohydrate Diets. Nutrients. 2021 Sep 22;13(10):3299. doi: 10.3390/nu13103299. Full article.

Walker RW, Dumke KA, Goran MI. Fructose content in popular beverages made with and without high-fructose corn syrup. Nutrition. 2014 Jul-Aug;30(7-8):928-35. doi: 10.1016/j.nut.2014.04.003. Full article.

Wang CH, Wei YH. Role of mitochondrial dysfunction and dysregulation of Ca2+ homeostasis in the pathophysiology of insulin resistance and type 2 diabetes. J Biomed Sci. 2017 Sep 7;24(1):70. doi: 10.1186/s12929-017-0375-3. Full article.

Wensveen FM, Jelenčić V, Valentić S, Šestan M, Wensveen TT, Theurich S, Glasner A, Mendrila D, Štimac D, Wunderlich FT, Brüning JC, Mandelboim O, Polić B. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol. 2015 Apr;16(4):376-85. doi: 10.1038/ni.3120. Abstract.

Willems AEM, Sura-de Jong M, van Beek AP, Nederhof E, van Dijk G. Effects of macronutrient intake in obesity: a meta-analysis of low-carbohydrate and low-fat diets on markers of the metabolic syndrome. Nutr Rev. 2021 Mar 9;79(4):429-444. doi: 10.1093/nutrit/nuaa044. Full article.

Wu Y, Ehlert B, Metwally AA, Perelman D, Park H, Brooks AW, Abbasi F, Michael B, Celli A, Bejikian C, Ayhan E, Lu Y, Lancaster SM, Hornburg D, Ramirez L, Bogumil D, Pollock S, Wong F, Bradley D, Gutjahr G, Rangan ES, Wang T, McGuire L, Venkat Rangan P, Ræder H, Shipony Z, Lipson D, McLaughlin T, Snyder MP. Individual variations in glycemic responses to carbohydrates and underlying metabolic physiology. Nat Med. 2025 Jul;31(7):2232-2243. doi: 10.1038/s41591-025-03719-2. Full article.

Xie D, Zhao H, Lu J, He F, Liu W, Yu W, Wang Q, Hisatome I, Yamamoto T, Koyama H, Cheng J. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. Am J Physiol Endocrinol Metab. 2021 Jun 1;320(6):E1032-E1043. doi: 10.1152/ajpendo.00518.2020. Full article.

Zhang CS, Hawley SA, Zong Y, Li M, Wang Z, Gray A, Ma T, Cui J, Feng JW, Zhu M, Wu YQ, Li TY, Ye Z, Lin SY, Yin H, Piao HL, Hardie DG, Lin SC. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature. 2017 Aug 3;548(7665):112-116. doi: 10.1038/nature23275. Full article.

Zheng T, Yang X, Wu D, Xing S, Bian F, Li W, Chi J, Bai X, Wu G, Chen X, Zhang Y, Jin S. Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway. Br J Pharmacol. 2015 Jul;172(13):3284-301. doi: 10.1111/bph.13120. Full article.